Hin Sang Group (International) Holding Co. Ltd. stock analysis
Want to see HK:6893 full AI Analyst Report?
Hin Sang Group (International) Holding Co. Ltd. (6893) Stock Price & Analysis
6893 Stock Chart & Stats
- Day’s Range
- HKD 0.31 - HKD 0.36
- 52-Week Range
- HKD 0.09 - HKD 0.42
- Previous Close
- HKD 0.33
- Volume
- N/A
- Average Volume (3M)
- 447.07K
- Market Cap
- HKD 360.29M
- Enterprise Value
- HKD 574.35M
- Total Cash (Recent Filing)
- HKD 21.81M
- Total Debt (Recent Filing)
- HKD 361.12M
- Price to Earnings (P/E)
- ―
- Beta
- -0.03
- Next Earnings
- Nov 26, 2026 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Dec 05, 2018
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue Growth
Sustained revenue growth of ~10.4% shows the company is expanding top-line traction in its category, a durable sign of demand and distribution execution. If management controls operating costs, this revenue base can support scaling and eventual margin recovery over the next several quarters.
Gross Profitability
A relatively healthy gross margin provides structural room to absorb SG&A and invest in product or distribution improvements. In household and personal products, above-baseline gross margins can sustain profitability if operating expenses are rationalized, aiding long-term margin recovery.
Moderate Equity Ratio
A moderate equity ratio indicates a non-trivial equity base backing assets, which offers some balance-sheet stability versus pure debt financing. This structural cushion can improve resilience to shocks and help preserve access to capital while the company works to address leverage and cash generation.
Bears Say
Persistent Losses
Ongoing net losses and negative operating margins are a structural concern: they erode equity and limit the company's ability to self-fund investment. Over a multi-quarter horizon, persistent unprofitability undermines sustainability and raises the urgency for durable cost or revenue improvements.
High Leverage
A debt-to-equity ratio above 2 creates meaningful fixed obligations and refinancing risk. Combined with weak profitability, high leverage constrains strategic flexibility, increases interest sensitivity, and heightens the risk of covenant stress or forced capital raises over the medium term.
Weak Cash Generation
Negative free cash flow growth and poor conversion of income to operating cash indicate structural liquidity weakness. Without generating positive cash internally, the company will likely rely on external financing, which can be dilutive or costly and impair its ability to invest in growth initiatives.
Hin Sang Group (International) Holding Co. Ltd. News
6893 FAQ
What was Hin Sang Group (International) Holding Co. Ltd.’s price range in the past 12 months?
What is Hin Sang Group (International) Holding Co. Ltd.’s market cap?
When is Hin Sang Group (International) Holding Co. Ltd.’s upcoming earnings report date?
How were Hin Sang Group (International) Holding Co. Ltd.’s earnings last quarter?
Is Hin Sang Group (International) Holding Co. Ltd. overvalued?
Does Hin Sang Group (International) Holding Co. Ltd. pay dividends?
What is Hin Sang Group (International) Holding Co. Ltd.’s EPS estimate?
How many shares outstanding does Hin Sang Group (International) Holding Co. Ltd. have?
What happened to Hin Sang Group (International) Holding Co. Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Hin Sang Group (International) Holding Co. Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Hin Sang Group (International) Holding Co. Ltd. Stock Smart Score
Company Description
Hin Sang Group (International) Holding Co. Ltd.
Hin Sang Group (International) Holding Co. Ltd., founded in 1996 and headquartered in Tsim Sha Tsui, Hong Kong, functions as a subsidiary of Genwealth Group Holding Company Limited. The company's core business revolves around developing, promoting, and selling healthcare products, with a particular emphasis on offerings for children, primarily serving the markets of Hong Kong and Mainland China. Its operations are strategically organized into four principal segments: 1. Product Development: This division focuses on creating and commercializing personal care products, household goods, and health supplements under proprietary brand names such as Hin Sang, Tai Wo Tong, Cheers Smart, Care Plus, Shuang Long, and King's Antiseptic. 2. Brand Development and Management: This unit specializes in the marketing, sales, distribution, logistics, and delivery of personal care products for brands including Pahmi, Enear, Vcnic, Zici, and Sunew, while also offering brand management and development services to other brand owners. 3. Trading of Goods: This segment handles the distribution and sale of skincare, personal care, and household products, procured from diverse sources like authorized dealers, independent traders, manufacturers, parallel importers, and various suppliers. 4. Healthcare: This division provides traditional Chinese medical services tailored for mothers and children, in addition to developing maternal and child health-related products and operating medical centers and hospitals. Beyond these primary activities, the group also engages in the trade of skincare, personal care, and slimming products, as well as property holding. The company's products are available to consumers directly in Hong Kong, through a robust distribution network spanning the People's Republic of China and Macau, and via online platforms.
- Sector
- Consumerdefensive
- Industry
- Household & Personal Products
- CEO
- Lai Man Kwan
- Employees
- 197
- Website
- www.hinsanggroup.com
- Address
- HK
Hin Sang Group (International) Holding Co. Ltd. (6893) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 13 | 6 | 3 |
| Technical Analysis | 4 | 6 | 0 |
| Moving Averages | 9 | 0 | 3 |






